Beike Biotech's 'Human Umbilical Cord Mesenchymal Stem Cell Therapy Technology for Type 2 Diabetes' officially approved at Boao Lecheng
On December 30, 2025, the Hainan Boao Lecheng Medical and Drug Administration officially approved Ciming Boao International Hospital to carry out the……
Important notice on guarding against the unauthorized use of the 'Beike Biotech' name in business activities
Shenzhen Beike Biotechnology Co., Ltd. issues a formal notice on the prevention of fraudulent use of the 'Beike Biotech' name in commercial activities,……
Process research from Beike Biotech's Preparation Center published in the renowned international journal Stem Cell Research & Therapy
The 2024 latest process research from Beike Biotech's Preparation Center has been published in the renowned international journal Stem Cell Research &……
Major news! Beike Biotech's in-house developed first domestic stem cell new drug for systemic lupus erythematosus approved for clinical trials
On April 28, 2024, Beike Biotech's in-house developed innovative cell drug 'Human Umbilical Cord Mesenchymal Stem Cell Injection' for the treatment of……
Beike Biotech invited to attend the SUSTech Global Excellence Innovation Talent Summer School information session, jointly building the future of biotechnology
On April 11, 2024, the Global Excellence Innovation Talent Summer School information session, co-hosted by Southern University of Science and Technology……
Chongqing Medicine and Beike Biotech jointly hold 'Symposium on Clinical Application and Translational Development of New Stem Cell Technologies'
On the afternoon of April 11, the 'Symposium on Clinical Application and Translational Development of New Stem Cell Technologies', co-hosted by the……
New standardization breakthrough! Beike Biotech-co-authored group standard 'General Requirements for Human-Derived Cell Storage Services' released!
Beike Biotech has once again demonstrated its active contribution to industry standardization.…
The 2024 latest research from Beike Biotech's empowered stem cell technology platform published in the leading international journal Cell & Bioscience!
The 2024 latest research from Beike Biotech's empowered stem cell technology platform has been published in the leading international journal Cell &……
Top international publisher Elsevier congratulates Dr. Liao Yan on her research's positive contribution to the UN Sustainable Development Goals!
Dr. Liao Yan of Beike Biotech's R&D Center recently received a letter of congratulations from the top international publisher Elsevier.…
Deepening industrial chain layout! Beike Biotech and Sino Biological reach a strategic partnership
On March 28, 2024, Shenzhen Beike Biotechnology Co., Ltd. (hereinafter 'Beike Biotech') and Beijing Sino Biological Inc.…
Innovation leads the way! Beike Biotech sweeps four honors including the 2023 Greater Bay Area Enterprise Innovation List
On the afternoon of March 14, themed 'Gathering industry-academia-research innovation momentum to build a high-quality development system', the 4th……
Kudos! Beike Biotech once again named one of the 'Top 100 Shenzhen Brands'!
Good news at the start of the new year! On February 27, 2024, the Shenzhen Quality Strong City Promotion Association released the list of the 3rd 'Top 100……